PharmaEssentia Reports the US FDA’s sBLA Acceptance of Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
Shots: Ref: Businesswire | Image: PharmaEssentia | Press Release Related News: PharmaEssentia Reports Topline Data…
Read article →
Zonsen PepLib Biotech Grants Novartis Global License for Radioligand Therapy Asset with $50M Upfront
Shots: Ref: PRnewswire | Image: PepLib & Novartis |Press Release Related News: SciNeuro Forges ~$1.7B Deal with Novartis…
Read article →
Summit Therapeutics Reports the US FDA’s BLA Submission for Ivonescimab to Treat EGFRm Non-Squamous NSCLC
Shots: Ref: Summit | Image: Summit | Press Release Related News: Summit Therapeutics Partners with Pfizer to Assess…
Read article →
The US FDA New Drug Approvals in December 2025
Shots: Company: LIB Therapeutics Product: Lerochol Active Ingredient: Lerodalcibep-liga Disease: Elevated LDL…
Read article →
Medtronic Reports 510(k) Clearance of MiniMed Go System for Diabetes Management
Shots: Ref: Medtronic | Image: Medtronic | Press Release Related News: Medtronic Receives the US FDA clearance for…
Read article →
BMS Reports P-III (SCOUT-HCM) Trial Findings on Camzyos for Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Shots: Ref: Businesswire | Image: BMS | Press Release Related News: Harbour BioMed and BMS Collaborate in ~$1.1B Deal to…
Read article →
Denali Therapeutics Announces Publishing of P-I/II Study of Tividenofusp Alfa (DNL310) in NEJM for Hunter Syndrome (MPS II)
Shots: Ref: Denali Therapeutics | Image: Denali | Press Release Related News: Delcath Systems Publishes Subgroup…
Read article →
BioAtla and GATC Health Announce $40M SPV Transaction to Advance Ozuriftamab Vedotin into P-III Study for 2L+ OPSCC
Shots: Ref: BioAtla |Image: BioAtla and GATC Health | Press Release Related News: Intelligent Bio Solutions and Syrma…
Read article →